aRigen Pharmaceuticals, Inc.が後援する臨床試験
合計5158件
-
OHSU Knight Cancer InstituteOregon Health and Science University; Progenics Pharmaceuticals, Inc.まだ募集していません
-
Peking Union Medical College HospitalMerck Sharp & Dohme LLC; BeyondSpring Pharmaceuticals Inc.募集
-
Italian Network for Tumor Biotherapy FoundationBristol-Myers Squibb; Astex Pharmaceuticals, Inc.まだ募集していません
-
University of MiamiWyeth-Ayesrst Pharmaceuticals, Roche Laboratories, and Fujusawa Healthcare, Inc.完了
-
Eloxx Pharmaceuticals, Inc.SGS Life Sciences, a division of SGS Belgium NV完了
-
Washington University School of MedicineMillennium Pharmaceuticals, Inc.; Multiple Myeloma Research Consortium積極的、募集していない
-
OHSU Knight Cancer InstituteOregon Health and Science University; AMAG Pharmaceuticals, Inc.引きこもった
-
University of Alabama at BirminghamBayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma完了
-
Hamid SayarBayer; Merck Sharp & Dohme LLC; Millennium Pharmaceuticals, Inc.完了
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Astex Pharmaceuticals, Inc.完了
-
Centre of Experimental MedicineMillennium Pharmaceuticals, Inc.終了しました
-
University of Alabama at BirminghamBayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma終了しました
-
Alison WalkerNovartis; Millennium Pharmaceuticals, Inc.完了急性骨髄性白血病 | 再発性成人急性骨髄性白血病 | 11q23 (MLL) 異常を伴う成人急性骨髄性白血病 | Del(5q)を伴う成人急性骨髄性白血病 | Inv(16)(p13;q22)を伴う成人急性骨髄性白血病 | T(16;16)(p13;q22)を伴う成人急性骨髄性白血病 | T(8;21)(q22;q22)を伴う成人急性骨髄性白血病 | 続発性急性骨髄性白血病 | 骨髄異形成症候群 | T(15;17)(q22;q12)を伴う成人急性骨髄性白血病 | 多系統異形成に続く急性骨髄性白血病アメリカ
-
Stanford UniversityMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.完了
-
University of Alabama at BirminghamNational Cancer Institute (NCI); Ionis Pharmaceuticals, Inc.完了
-
Vanderbilt University Medical CenterTeva Branded Pharmaceutical Products R&D, Inc.募集
-
Nanogen Pharmaceutical Biotechnology Joint Stock...Vietstar Biomedical Research; MedProve Inc完了
-
Nanogen Pharmaceutical Biotechnology Joint Stock...Vietstar Biomedical Research; MedProve Inc完了
-
Teva Branded Pharmaceutical Products R&D, Inc.National Cancer Institute (NCI)終了しました多形性膠芽腫 | 退形成性星細胞腫 | 未分化乏突起膠腫 | 退形成性混合型オリゴ星細胞腫
-
Teva Branded Pharmaceutical Products R&D, Inc.Cetero Research, San Antonio完了
-
University of California, San FranciscoBayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharmaまだ募集していません
-
Laminar PharmaceuticalsDana-Farber Cancer Institute; Hackensack Meridian Health; Laminar Pharma Inc募集
-
Carsten Bindslev-JensenNovartis Pharmaceuticals; Thermo Fisher Scientific, Inc完了
-
Memorial Sloan Kettering Cancer CenterJanssen Scientific Affairs, LLC; Xynomic Pharmaceuticals, Inc.積極的、募集していない
-
European Organisation for Research and Treatment...Tragara Pharmaceuticals, Inc.完了膠芽腫 | 星細胞腫、グレード IIIフランス, オーストリア, ドイツ, オランダ, スイス
-
Spectrum Pharmaceuticals, IncNational Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center完了
-
University of California, DavisNational Cancer Institute (NCI); Genentech, Inc.; Aventis Pharmaceuticals完了
-
Fondazione MichelangeloFondazione IRCCS Istituto Nazionale dei Tumori, Milano; Millennium Pharmaceuticals, Inc.完了
-
Mayo ClinicNational Heart, Lung, and Blood Institute (NHLBI); Aires Pharmaceuticals, Inc.完了
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Millennium Pharmaceuticals, Inc.完了
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI); GlaxoSmithKline; Millennium Pharmaceuticals, Inc.終了しました再発成人びまん性大細胞型リンパ腫 | 再発グレード1の濾胞性リンパ腫 | 再発グレード2濾胞性リンパ腫 | 再発グレード 3 濾胞性リンパ腫 | 再発マントル細胞リンパ腫アメリカ
-
Genzyme, a Sanofi CompanyBayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma完了B細胞性慢性リンパ性白血病(B-CLL)イギリス, ベルギー, フランス, アメリカ, チェコ共和国, セルビア
-
Stanford UniversityMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.完了
-
Guang'anmen Hospital of China Academy of Chinese...Tasly Pharmaceuticals, Inc.完了
-
Santalis Pharmaceuticals, Inc.Derm Research, PLLC; ClinDatrix, Inc.; Clinical Trials of Texas, Inc.; Progressive Clinical Research と他の協力者完了
-
Stefanie Sarantopoulos, MD, PhD.National Institutes of Health (NIH); Incyte Corporation; Rigel Pharmaceuticalsまだ募集していません
-
SFJ Pharmaceuticals X, LTD.Merck KGaA, Darmstadt, Germany; AIO-Studien-gGmbH; Academic and Community Cancer Research United; SFJ Pharmaceuticals, Inc...引きこもった
-
LUNGevity FoundationBristol-Myers Squibb; Eli Lilly and Company; Merck Sharp & Dohme LLC; Novartis; Takeda; AstraZeneca; Genentech... と他の協力者募集
-
UNC Lineberger Comprehensive Cancer CenterBristol-Myers Squibb; Amgen積極的、募集していない
-
The Third Xiangya Hospital of Central South UniversityLivzon Pharmaceutical Group Inc.; Yung Shin Pharm. Ind. Co., Ltd.完了
-
Biologics & Biosimilars Collective Intelligence...Merck Sharp & Dohme LLC; Pfizer; AbbVie; University of Pittsburgh; Boehringer Ingelheim; Kaiser Permanente と他の協力者完了
-
McGill University Health Centre/Research Institute...Sanofi; Merck Sharp & Dohme LLC; Pfizer; Amgen; Aegerion Pharmaceuticals, Inc.; Valeant Canada Limited募集
-
Biologics & Biosimilars Collective Intelligence...Merck Sharp & Dohme LLC; Pfizer; AbbVie; University of Pittsburgh; Boehringer Ingelheim; Kaiser Permanente と他の協力者完了関節リウマチ | 乾癬 | 乾癬性関節炎 | 炎症性腸疾患 | 強直性脊椎炎
-
Martha SajatovicOtsuka Pharmaceutical Development & Commercialization, Inc.完了
-
Otsuka Pharmaceutical Development & Commercialization...H. Lundbeck A/S; PRA Health Sciences完了
-
Seung-Jung ParkOtsuka Pharmaceutical Development & Commercialization, Inc.終了しました
-
Teva Branded Pharmaceutical Products R&D, Inc.United States Department of Defense引きこもった
-
Teva Branded Pharmaceutical Products R&D, Inc.Clalit Health Services; Rosetta Genomics完了
-
Johnson & Johnson Pharmaceutical Research & Development...PriCara, Unit of Ortho-McNeil, Inc.完了